Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure

Abstract

Neural precursor cells (NPCs) populate the embryonic ventricular zone and persist in the subependymal zone of the adult brain. We hypothesized that hereditary and/or acquired mutations in apoptosis-associated genes, such as p53 and caspases, may protect NPCs from DNA damage-induced death and predispose them to subsequent neoplastic transformation. To test this hypothesis, we exposed NPCs from wild-type and targeted gene-disrupted mouse embryos (p53, caspase-9, caspase-3, and bax mutants) to ethyl-nitrosourea (ENU), a known DNA mutagen and neural carcinogen, and measured NPC viability. We found that ENU produced caspase-3 activation and apoptotic NPC death 6–24 h after administration both in vivo and in vitro. This effect was critically dependent on p53 and caspase-9 expression. The long-term effect of intrauterine ENU exposure was examined in control and p53-deficient mice. High grade glial tumors were found in 60% of p53−/− young adult mice exposed to ENU on gestational day 12.5 but not in p53+/− or p53+/+ littermates or in untreated p53-deficient mice. All the tumors were located supratentorially and possessed strong immunoreactivity for glial fibrillary acidic protein and the anti-apoptotic molecule Bcl-XL. These results suggest that intrauterine exposure of NPCs to certain DNA damaging agents may synergistically interact with specific genetic abnormalities (e.g. p53 deficiency) to produce glial neoplasms in the adult brain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Aloyz RS, Bamji SX, Pozniak CD, Toma JG, Atwal J . 1998 J. Cell Biol. 143: 1691–1703

  • Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, Alnemri ES, Litwack G, Karanewsky DS, Fritz LC, Tomaselli KJ . 1997 J. Neurosci. 17: 553–562

  • Bilzer T, Reifenberger G, Wechsler W . 1989 Neurotoxicol. Teratol. 11: 551–556

  • Bruggers CS, Fults D, Perkins SL, Coffin CM, Carroll WL . 1999 J. Pediatr. Hematol./Oncol. 21: 19–25

  • D'Sa-Eipper C, Leonard JR, Putcha G, Zheng TS, Flavell RA, Rakic P, Kuida K, Roth KA . 2001 Development 128: 137–146

  • D'Sa-Eipper C, Roth KA . 2000 Devel. Neurosci. 22: 116–124

  • Diwan BA, Meier H . 1974 Cancer Res. 34: 764–770

  • Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylia A . 1999 Cell 97: 703–716

  • Dole M, Nuñez G, Merchant AK, Maybaum J, Rode CK, Block CA, Castle VP . 1994 Cancer Res. 54: 3253–3259

  • Dole MG, Jasty R, Cooper MJ, Thompson CB, Nuñez G, Castle VP . 1995 Cancer Res. 55: 2576–2582

  • Druckrey H, Ivankovic S, Preussmann R . 1966 Nature 210: 1378–1379

  • Eves EM, Boise LH, Thompson CB, Wagner AJ, Hay N, Rosner MR . 1996 J. Neurochem. 67: 1908–1920

  • Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng H-L, Davidson L, Kangaloo L, Alt FW . 1998 Nature 396: 173–177

  • Haydar TF, Wang F, Schwartz ML, Rakic P . 2000 J. Neurosci. 20: 5764–5774

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA . 1994 Curr. Biol. 4: 1–7

  • Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J . 1999 Cell 96: 25–34

  • Johnson MD, Kinoshita Y, Xiang H, Ghatan S, Morrison RS . 1999 J. Neurosci. 19: 2996–3006

  • Johnson MD, Xiang H, London S, Kinoshita Y, Knudson M, Mayberg M, Korsmeyer SJ, Morrison RS . 1998 J. Neurosci. Res. 54: 721–733

  • Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Cavenee WK . 2000 World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. Kheihues P and Cavenee WK (ed) IARC Press: Lyon pp. 29–39

  • Klein MA, Rüedi D, Nozaki M, Dell EW, Diserens A-C, Seelentag W, Janzer RC, Aguzzi A, Hegi ME . 2000 Oncogene 19: 5329–5337

  • Krajewski S, Krajewski M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JC . 1997 Am. J. Path. 150: 805–814

  • Liu R, Page C, Beidler DR, Wicha MS, Núñez G . 1999 Am. J. Pathol. 155: 1861–1867

  • McKay R . 1997 Science 276: 66–71

  • Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K-I, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY . 1995 Science 267: 1506–1510

  • Oda H, Zhang S, Tsurutani N, Shimizu S, Nakatsuru Y, Aizawa S, Ishikawa T . 1997 Cancer Res. 57: 646–650

  • Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan C-Y, Rakic P . 2001 J. Neurosci. 21: 4752–4760

  • Rao MS . 1999 The Anatomical Record 257: 137–148

  • Roth KA, Kuan C-Y, Haydar TF, D'Sa-Eipper C, Shindler KS, Zheng TS, Kuida K, Flavell RA, Rakic P . 2000 Proc. Natl. Acad. Sci. USA 97: 466–471

  • Schlegel J, Stumm G, Mennel HD . 1993 Exp. Toxic Pathol. 45: 455–466

  • Shindler KS, Latham CB, Roth KA . 1997 J. Neurosci. 17: 3112–3119

  • Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomaselli KJ . 1998 Cell Death Diff. 5: 1004–1016

  • Stiles CD . 1998 Biochimica. et Biophysica. Acta. 1377: R1–R10

  • Timme T, Thompson TC . 1994 BioTechniques 17: 461–463

  • Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H . 1997 Clin. Cancer Res. 3: 523–530

  • Wechsler W, Kleihues P, Matsumoto S, Zülch KJ, Ivankovic S, Preussmann R, Druckrey H . 1969 Ann. NY Acad. Sci. 159: 360–408

  • Wechsler W, Rice JM, Vasselinovitch SD . 1979 Natl. Cancer Inst. Monogr. 51: 219–226

  • Zaidi AU, D'Sa-Eipper C, Brenner J, Kuida K, Zheng TS, Flavell RA, Rakic P, Roth KA . 2001 J. Neurosci. 21: 169–175

  • Zheng TS, Schlosser SF, Dao T, Hingorani R, Crispe IN, Boyer JL, Flavell RA . 1998 Proc. Natl. Acad. Sci. USA 95: 13618–13623

Download references

Acknowledgements

We thank C Latham and J McDonough for expert technical assistance; and A Schmeckebier for secretarial support. Caspase-3 and caspase-9 mutant mice were generously provided by Dr RA Flavell (Yale University). CM1 antiserum was provided by Dr A Srinivasan (IDUN Pharmaceuticals, Inc.). This work was supported by postdoctoral training grant DK07296 to C D'Sa and grants from the Public Health Service to KA Roth.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin A Roth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leonard, J., D'Sa, C., Klocke, B. et al. Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure. Oncogene 20, 8281–8286 (2001). https://doi.org/10.1038/sj.onc.1205024

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205024

Keywords

This article is cited by

Search

Quick links